This volume will outline how to recreate the tumor microenvironment, to
culture primary tumors without the need for developmental priming
factors, and to deliver targeted therapeutics in a manner that
recapitulates pharmacokinetics in vivo. Much of what may be learned
from this volume will aid in understanding many aspects of the enhanced
study of tumor cell biology in a physiologic context, open new avenues
for drug screening and biomarker development, and accelerate the
preclinical evaluation of novel personalized medicine strategies for
patients in real time.